Evidence map›Paper›PMID 23955702›Full record

ArticlePsychopharmacology2014

Cortical glutathione levels in young people with bipolar disorder: a pilot study using magnetic resonance spectroscopy.

Beata R Godlewska, Sarah W Yip, Jamie Near, Guy M Goodwin, Philip J Cowen

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03220776 (Imaging Framework for Testing GABAergic/Glutamatergic Drugs in Bipolar Alcoholics), which is not on this map. Cited by 21 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 4 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03220776 phase2completednot on this mapstarted 2017, after this paper: background citation

Imaging Framework for Testing GABAergic/Glutamatergic Drugs in Bipolar Alcoholics

TypeinterventionalSponsorMedical University of South CarolinaRan2017 to 2022Enrolled54ConditionsAlcohol Use Disorder, Bipolar DisorderArmsN-Acetylcysteine, Gabapentin, Placebo Oral Tablet
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 4 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Biomarkers of bipolar disorder in omics and neuroimaging.Journal of pharmaceutical analysis · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Cortical and subcortical glutathione levels in adults with autism spectrum disorder.Autism research : official journal of the International Society for Autism Research · 2016
    Article
  18. Review
  19. Article
  20. Hypoactivation of the ventral and dorsal striatum during reward and loss anticipation in antipsychotic and mood stabilizer-naive bipolar disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Beata R GodlewskaUniversity Department of Psychiatry, Warneford Hospital, Oxford, OX3 7JX, UK.
Sarah W Yip
Jamie Near
Guy M Goodwin
Philip J Cowen
Warneford Hospital · GBWellcome Centre for Integrative Neuroimaging · GB

Funding

Medical Research Council G0701421
6 · The paper itself

Abstract

rationaleGlutathione (GSH) is a key scavenger for cellular free radicals, and patients with bipolar disorder may have lowered GSH levels in plasma and in post-mortem brain tissue.

objectivesThe objective of the current study was to use magnetic resonance spectroscopy (MRS) to measure cortical GSH levels in young people with bipolar disorder to determine if lowered GSH might be a useful biomarker of vulnerability to the illness.

methodsWe studied 13 patients with DSM-IV bipolar disorder and 11 healthy age-matched controls using proton MRS in conjunction with the SPECIAL acquisition technique. Voxels were placed in prefrontal and occipital cortex. All patients were clinically euthymic at the time of study and unmedicated. GSH and other relevant neurometabolites were measured relative to creatinine.

resultsThere was no difference in GSH levels between bipolar participants and controls in either prefrontal or occipital cortex. Similarly, participants showed no difference from controls in other measured cortical metabolites including γ-aminobutyric acid, glutamate and N-acetylaspartate.

conclusionsThis pilot study suggests that levels of cortical GSH are unlikely to be a useful trait biomarker of bipolar disorder in young people with a history of relatively mild mood instability at an early stage of illness. Lowered GSH levels may be relevant to bipolar pathophysiology in more severely ill patients, particular those with significant current mood disturbance.

Indexed as

Aspartic AcidBiomarkersBipolar DisorderCase-Control StudiesFemaleFunctional Neuroimaginggamma-Aminobutyric AcidGlutamic AcidGlutathioneHumansMagnetic Resonance SpectroscopyMaleOccipital LobePilot ProjectsPrefrontal CortexYoung AdultAspartic AcidBiomarkersgamma-Aminobutyric AcidGlutamic AcidGlutathioneN-acetylaspartate

Identifiers

PMID23955702
OpenAlexW2037078651

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.